Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anton E Koziakov"'
Autor:
Vera A Gorbunova, Irina V Kolyadina, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Tat'iana Iu Semiglazova, Aleksei G Manikhas, Natal'ia A Raevskaia, Il'ia M Itkin, Dmitrii V Filonenko, Larisa A Zhilyaeva, Viktor E Gol'dberg, Natal'ia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Irina R Suslova, Olga V Romanchuk, Dmitrii V Kozlov, Ali-Dzarakhmat S Rzaev, Vasilii V Marfutov, Irina I Andreiashkina, Liubov' I Vladimirova, Irina S Mitashok, Natal'ia M Tikhanovskaia, Elena V Karabina, Guzel' Z Mukhametshina, Al'fiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Dmitrii A Morozov, Elena P Prokof'eva, Liudmila V Kramskaia, Tat'iana V Karandeeva, Irina V Evstigneeva, Elena G Ovchinnikova, Tat'iana P Klement'eva, Olga V Khrupalo, Elena V Tiuvinova, Viktor M Sherstnev, Igor' S Chernov, Dzheims Dzh Kolokolov, Elena A Gaisina, Natal'ia V Levchenko, Viacheslav A Chubenko, Anton Iu Povyshev, Inna V Iudina, Liudmila V Vorotilina, Tat'iana V Andreeva, Garnik S Tumanian, Anton E Koziakov, Liudmila A Gil'mutdinova, Mikhail A Osipov, Alina S Shatokhina, Alena A Vazhenina, Angelina S Chichkanova, Vladimir I Vladimirov, Aleksandr N Ivanov, Anna S Belokhvostova, Elena M Cherniakova, Elena A Tul'china, Svetlana A Maklashova, Oksana N Shkodenko, Iuliia V Kostalanova, Anna V Tarasova, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://doaj.org/article/fab8f79eb72a4ebeb4af3ca5e29be2e9
Autor:
Elena I. Kovalenko, Elena V. Artamonova, Elena V. Karabina, Irina I. Andreiashkina, Ekaterina A. Prokof’eva, Nataliia O. Popova, Elena A. Gaisina, Irina V. Evstigneeva, Mikhail V. Shaidorov, Larisa A. Zhiliaeva, Dmitrii M. Ponomarenko, Alfiia I. Khasanova, Guzel Z. Mukhametshina, Anton E. Koziakov, Liudmila V. Vorotilina, Anton Iu. Povyshev, Elena I. Simolina, Vasilii V. Marfutov, Dmitrii V. Kozlov, Irina R. Suslova, Valentina E. Shikina, Tatiana V. Karandeeva, Artem O. Shepel’, Liudmila V. Kramskaia, Denis A. Oskirko, Olga S. Frolova
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 53-59 (2020)
The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of metastatic HER2+ breast cancer in routine clinical practice. Aim. The main objective of thi
Externí odkaz:
https://doaj.org/article/348c12ae10644482a51e5fd30b93fd11
Autor:
Mikhail V Shaidorov, Elena I. Simolina, Elena V. Artamonova, Denis A. Oskirko, Irina R. Suslova, Ekaterina A. Prokof’eva, Liudmila V. Kramskaia, Dmitrii V. Kozlov, Anton Iu Povyshev, Elena A. Gaisina, Irina I. Andreiashkina, Olga S. Frolova, Elena I. Kovalenko, Liudmila V. Vorotilina, Elena Karabina, Larisa A. Zhiliaeva, Tat'iana V Karandeeva, Guzel' Z Mukhametshina, Dmitrii M Ponomarenko, Artem O. Shepel, Al'fiia I Khasanova, Vasilii V. Marfutov, Valentina E Shikina, Irina V. Evstigneeva, Nataliia O. Popova, Anton E. Koziakov
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 53-59 (2020)
The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of metastatic HER2+ breast cancer in routine clinical practice. Aim. The main objective of this r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea255c31ce421f5e2548d0e28cb3b9df
https://modernonco.orscience.ru/1815-1434/article/viewFile/34173/22585
https://modernonco.orscience.ru/1815-1434/article/viewFile/34173/22585
Autor:
Natal'ia M Tikhanovskaia, Elena Karabina, Igor' S Chernov, Tat'iana V Karandeeva, Mikhail A Osipov, Irina V. Kolyadina, Ali-Dzarakhmat S Rzaev, Dmitrii V. Kozlov, Sufiia Z Safina, Vasilii V. Marfutov, Elena P Prokof'eva, Oksana N Shkodenko, Alena A Vazhenina, Tat'iana V Andreeva, Elena G. Ovchinnikova, Irina R. Suslova, Elena I. Kovalenko, Olga V Khrupalo, Tat'iana Iu Semiglazova, Liudmila V. Vorotilina, Irina I. Andreiashkina, Elena V. Artamonova, Anton Iu Povyshev, Angelina S Chichkanova, Olga V Romanchuk, Vera A Gorbunova, Liubov' I Vladimirova, Elena A. Gaisina, Garnik S Tumanian, Iuliia V Kostalanova, Liudmila A Gil'mutdinova, Irina S Mitashok, Liudmila V Manziuk, Dmitrii M Ponomarenko, Evgeniia S Kuz'mina, Al'fiia I Khasanova, Guzel' Z Mukhametshina, Vladimir I. Vladimirov, Dmitrii A Morozov, Liudmila V. Kramskaia, Mikhail V Shaidorov, V E Goldberg, Inna V Iudina, Valentina E Shikina, Liudmila G. Zhukova, N. O. Popova, Irina V. Evstigneeva, Anton E. Koziakov, Elena A Tul'china, Elena V Tiuvinova, Il'ia M Itkin, Alina S Shatokhina, Aleksei G Manikhas, Dzheims Dzh Kolokolov, Anna S Belokhvostova, Natal'ia V Levchenko, Svetlana A Maklashova, Aleksandr N Ivanov, Larisa Bolotina, Anna V Tarasova, Dmitrii V Filonenko, Viacheslav A. Chubenko, Natal'ia A Raevskaia, Viktor M Sherstnev, Elena M Cherniakova, Tat'iana P Klement'eva, Larisa A Zhilyaeva
Publikováno v:
Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)
Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6a2dd4170f83bf2d09813743b639af
https://doi.org/10.26442/18151434.2019.1.190250
https://doi.org/10.26442/18151434.2019.1.190250